![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Mol. Biosci. , 29 April 2022
Sec. Structural Biology
Volume 9 - 2022 | https://doi.org/10.3389/fmolb.2022.915838
This article is a correction to:
In silico Analysis Revealed Potential Anti-SARS-CoV-2 Main Protease Activity by the Zonulin Inhibitor Larazotide Acetate
A Corrigendum on
Overcome Chemoresistance: Biophysical and Structural Analysis of Synthetic FHIT-Derived Peptides
by Scala, M. C., Di Micco, S., Lanzillotta, D., Musella, S., Di Sarno, V., Parrino, B., Cascioferro, S. M., Bifulco, G., Trapasso, F., Campiglia, P., and Sala, M. (2021). Front. Mol. Biosci. 8:715263. doi: 10.3389/fmolb.2021.715263
An author name was incorrectly spelled as “Stella Maria Casciofierro”. The correct spelling is “Stella Maria Cascioferro”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: chemoresistance, peptide, FHIT, annexin A4, biophysical assay
Citation: Scala MC, Di Micco S, Lanzillotta D, Musella S, Di Sarno V, Parrino B, Cascioferro SM, Bifulco G, Trapasso F, Campiglia P and Sala M (2022) Corrigendum: Overcome Chemoresistance: Biophysical and Structural Analysis of Synthetic FHIT-Derived Peptides. Front. Mol. Biosci. 9:915838. doi: 10.3389/fmolb.2022.915838
Received: 08 April 2022; Accepted: 12 April 2022;
Published: 29 April 2022.
Approved by:
Frontiers Editorial Biosciences, Frontiers Media SA, SwitzerlandCopyright © 2022 Scala, Di Micco, Lanzillotta, Musella, Di Sarno, Parrino, Cascioferro, Bifulco, Trapasso, Campiglia and Sala. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Marina Sala, bXNhbGFAdW5pc2EuaXQ=
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.